Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
5
×
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
5
×
wisconsin top stories
biotech
alzheimer's disease
bristol-myers squibb
cancer
celgene
clinical trials
eli lilly
abbvie
aducanumab
astrazeneca
biogen
boehringer ingelheim
cancer immunotherapy
What
bio
roundup
week
5
×
drug
alzheimer’s
biogen
news
acquisitions
adu
aducanumab
amyloid
angst
annual
approved
arena’s
assessed
attention
bagged
beats
bids
biggest
billions
biogen’s
biotech
bounty
brammer
build
buy
ceo
cig
comeback
communities
companies
company’s
complicated
conference
corner
daniel
deals
debut
Language
unset
Current search:
week
×
" san francisco blog main "
×
pfizer
×
" wisconsin blog main "
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More